Brokerages Anticipate LHC Group, Inc. (NASDAQ:LHCG) to Post $1.00 Earnings Per Share

Analysts predict that LHC Group, Inc. (NASDAQ:LHCG) will report earnings of $1.00 per share for the current quarter, according to Zacks Investment Research. Five analysts have issued estimates for LHC Group’s earnings, with the highest EPS estimate coming in at $1.02 and the lowest estimate coming in at $0.98. LHC Group reported earnings of $0.84 per share in the same quarter last year, which indicates a positive year-over-year growth rate of 19%. The firm is expected to announce its next earnings report on Wednesday, August 7th.

According to Zacks, analysts expect that LHC Group will report full-year earnings of $4.30 per share for the current financial year, with EPS estimates ranging from $4.29 to $4.32. For the next financial year, analysts forecast that the company will report earnings of $4.57 per share, with EPS estimates ranging from $4.37 to $4.73. Zacks Investment Research’s EPS calculations are an average based on a survey of sell-side research firms that cover LHC Group.

LHC Group (NASDAQ:LHCG) last issued its earnings results on Wednesday, May 8th. The health services provider reported $0.98 EPS for the quarter, beating analysts’ consensus estimates of $0.90 by $0.08. The business had revenue of $502.59 million during the quarter, compared to analyst estimates of $511.16 million. LHC Group had a return on equity of 8.43% and a net margin of 3.83%.

LHCG has been the subject of a number of recent research reports. BidaskClub upgraded LHC Group from a “hold” rating to a “buy” rating in a research note on Tuesday, April 30th. UBS Group set a $133.00 target price on LHC Group and gave the company a “buy” rating in a research note on Friday, May 10th. SunTrust Banks upped their target price on LHC Group to $130.00 and gave the company a “buy” rating in a research note on Friday, March 1st. Royal Bank of Canada upped their target price on LHC Group to $130.00 and gave the company an “outperform” rating in a research note on Monday, May 13th. Finally, Robert W. Baird upped their target price on LHC Group from $98.00 to $120.00 and gave the company a “neutral” rating in a research note on Monday, March 4th. Four investment analysts have rated the stock with a hold rating and ten have issued a buy rating to the company. The stock presently has a consensus rating of “Buy” and a consensus price target of $120.58.

Shares of NASDAQ LHCG traded up $2.60 during trading hours on Monday, reaching $117.24. The stock had a trading volume of 10,461 shares, compared to its average volume of 178,803. The company has a current ratio of 1.57, a quick ratio of 1.57 and a debt-to-equity ratio of 0.21. The firm has a market capitalization of $3.65 billion, a price-to-earnings ratio of 32.88, a PEG ratio of 1.95 and a beta of 0.83. LHC Group has a twelve month low of $80.84 and a twelve month high of $122.20.

In other LHC Group news, COO Donald Dwayne Stelly sold 448 shares of the company’s stock in a transaction on Thursday, May 16th. The stock was sold at an average price of $120.00, for a total value of $53,760.00. Following the sale, the chief operating officer now directly owns 91,252 shares in the company, valued at $10,950,240. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Ronald T. Nixon sold 12,000 shares of the company’s stock in a transaction on Wednesday, May 22nd. The shares were sold at an average price of $117.20, for a total value of $1,406,400.00. Following the completion of the sale, the director now owns 29,100 shares in the company, valued at $3,410,520. The disclosure for this sale can be found here. Insiders sold 62,991 shares of company stock worth $7,134,055 over the last quarter. Company insiders own 5.20% of the company’s stock.

A number of large investors have recently made changes to their positions in LHCG. Parallel Advisors LLC boosted its holdings in LHC Group by 790.0% in the first quarter. Parallel Advisors LLC now owns 267 shares of the health services provider’s stock valued at $30,000 after acquiring an additional 237 shares during the last quarter. Sageworth Trust Co bought a new position in LHC Group in the first quarter valued at about $36,000. Quadrant Capital Group LLC boosted its holdings in LHC Group by 1,045.7% in the first quarter. Quadrant Capital Group LLC now owns 527 shares of the health services provider’s stock valued at $57,000 after acquiring an additional 481 shares during the last quarter. Meeder Asset Management Inc. bought a new position in LHC Group in the first quarter valued at about $68,000. Finally, Private Capital Group LLC boosted its holdings in LHC Group by 24.4% in the first quarter. Private Capital Group LLC now owns 1,116 shares of the health services provider’s stock valued at $124,000 after acquiring an additional 219 shares during the last quarter. Hedge funds and other institutional investors own 91.42% of the company’s stock.

LHC Group Company Profile

LHC Group, Inc provides post-acute health care services to patients through its home nursing agencies, hospices and long-term acute care hospitals. The company operates through the following business segments: Home Health Services, Hospice Services, Home & Community-Based Services, Facility-Based Services and Healthcare Innovations.

Read More: What is included in the gross domestic product?

Get a free copy of the Zacks research report on LHC Group (LHCG)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for LHC Group (NASDAQ:LHCG)

Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.